SCHEMBL186176

SCHEMBL186176

Nc1ncc(OC(=O)O)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
GABRP O00591 3/20 0.38
GABRD O14764 3/20 0.38
GABRA1 P14867 3/20 0.38
GABRB1 P18505 3/20 0.38
GABRG2 P18507 3/20 0.38
GABRB3 P28472 3/20 0.38
GABRA5 P31644 3/20 0.38
GABRA3 P34903 3/20 0.38
GABRA2 P47869 3/20 0.38
GABRB2 P47870 3/20 0.38
GABRA4 P48169 3/20 0.38
GABRE P78334 3/20 0.38
GABRA6 Q16445 3/20 0.38
GABRG1 Q8N1C3 3/20 0.38
GABRG3 Q99928 3/20 0.38
GABRQ Q9UN88 3/20 0.38
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28049475 0.84 ALDH1A1 (0.45) HDAC1HDAC6ALDH1A1KDM4EHSP90AA1
SCHEMBL29225190 0.82 KMT2A (0.45) HDAC1HDAC6GABRPGABRDGABRA1
SCHEMBL185449 0.79 ALDH1A1 (0.33) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7020112 0.79 ALDH1A1 (0.33) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9235248 0.78 GABRP (0.53) HDAC1HDAC6GABRPGABRDGABRA1
SCHEMBL185620 0.77 LMNA (0.35) ALDH1A1KDM4EMEN1LMNAKMT2A
SCHEMBL10588692 0.77 HDAC1 (0.42) HDAC1HDAC6ALDH1A1KDM4EHSP90AA1
SCHEMBL27503300 0.77 THRB (0.40) HDAC1HDAC6GABRPGABRDGABRA1
SCHEMBL27548231 0.77 PARP10 (0.54) ALDH1A1MEN1LMNAKMT2ASMN1; SMN2
SCHEMBL185429 0.74 ALDH1A1 (0.40) ALDH1A1KDM4ELMNAKMT2ANNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed
EP-0325131-A2 Pyrimidine derivatives as performance stimulating agents BAYER AG (DE) 1989-07-26 EP disclosed